BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 25840835)

  • 21. Perioperative, oncologic, and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy: a matched pair analysis.
    Klatte T; Mauermann J; Heinz-Peer G; Waldert M; Weibl P; Klingler HC; Remzi M
    J Endourol; 2011 Jun; 25(6):991-7. PubMed ID: 21568698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous Cryoablation of Renal Cell Carcinoma with Sinus Vein Involvement Based on Preprocedural Imaging.
    Atwell TD; Kurup AN; Boorjian SA; Schmitz JJ; Thompson RH; Leibovich BC; Schmit GD
    J Vasc Interv Radiol; 2017 Dec; 28(12):1651-1657. PubMed ID: 29042169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience.
    Tanagho YS; Bhayani SB; Kim EH; Figenshau RS
    J Endourol; 2013 Dec; 27(12):1477-86. PubMed ID: 24283518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous Cryoablation for the Treatment of Primary and Metastatic Lung Tumors: Identification of Risk Factors for Recurrence and Major Complications.
    McDevitt JL; Mouli SK; Nemcek AA; Lewandowski RJ; Salem R; Sato KT
    J Vasc Interv Radiol; 2016 Sep; 27(9):1371-1379. PubMed ID: 27321886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous renal cryoablation in obese and morbidly obese patients.
    Schmit GD; Thompson RH; Boorjian SA; McDonald RJ; Kurup AN; Weisbrod AJ; Kor DJ; Callstrom MR; Atwell TD
    Urology; 2013 Sep; 82(3):636-41. PubMed ID: 23890665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
    Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous renal cryoablation: experience treating 115 tumors.
    Atwell TD; Farrell MA; Leibovich BC; Callstrom MR; Chow GK; Blute ML; Charboneau JW
    J Urol; 2008 Jun; 179(6):2136-40; discussion 2140-1. PubMed ID: 18423719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic vs percutaneous cryoablation for the small renal mass: 15-year experience at a single center.
    Zargar H; Samarasekera D; Khalifeh A; Remer EM; O'Malley C; Akca O; Autorino R; Kaouk JH
    Urology; 2015 Apr; 85(4):850-5. PubMed ID: 25704992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease.
    Wehrenberg-Klee E; Clark TW; Malkowicz SB; Soulen MC; Wein AJ; Mondschein JI; Van Arsdalen K; Guzzo TJ; Stavropoulos SW
    J Vasc Interv Radiol; 2012 Jan; 23(1):41-5. PubMed ID: 22019179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome.
    Atwell TD; Farrell MA; Callstrom MR; Charboneau JW; Leibovich BC; Frank I; Patterson DE
    AJR Am J Roentgenol; 2007 May; 188(5):1195-200. PubMed ID: 17449758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of CT-guided percutaneous cryoablation for renal cell carcinoma.
    Georgiades CS; Hong K; Bizzell C; Geschwind JF; Rodriguez R
    J Vasc Interv Radiol; 2008 Sep; 19(9):1302-10. PubMed ID: 18725093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery.
    Morgan MA; Roberts NR; Pino LA; Trabulsi EJ; Brown DB; Gomella LG; Lallas CD
    Can J Urol; 2013 Oct; 20(5):6933-7. PubMed ID: 24128832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
    Zhou W; Arellano RS
    J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation.
    Beksac AT; Rivera-Sanfeliz G; Dufour CA; Nseyo U; Hamilton Z; Berquist SW; Hassan AE; Raheem OA; Wang S; Wake RW; Gold RE; Derweesh IH
    World J Urol; 2017 Apr; 35(4):633-640. PubMed ID: 27484204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
    Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
    Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Image-guided percutaneous renal cryoablation for stage 1 renal cell carcinoma with high surgical risk.
    Yan X; Zhang M; Chen X; Wei W; Yang R; Yang Y; Gan W; Guo H; Wang Y; Shi GP
    World J Surg Oncol; 2015 Jun; 13():200. PubMed ID: 26059547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.